AzTrials
AzTrials

Clinical trials: Corneal Epithelial Degeneration

What
Where
Study
Who can join
Dates
Clear all

1 study

  • Corneal Epithelial Degeneration

    Dose Escalation TTHX1114 Ophthalmic Solution

    • Completed
    • Age: 18 to 65 years
    • Phase 1

    Dose escalation 3+3 design with accelerated titration 4 dose levels

    Trial name
    EPI (NCT05769920)
    Testing
    TTHX1114(NM141) Ophthalmic Solution
    Where
    United States
    Volunteers
    8 people, healthy volunteers welcome
    Sponsor
    Trefoil Therapeutics, Inc.
    Can I take part? EPI

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in